DOI QR코드

DOI QR Code

Characteristics of Middle Aged Depressed Women with Hot Flushes

안면 홍조 증상을 수반한 중년 우울증 여성의 특성

  • Song, Minjae (Department of Psychiatry, Korea University College of Medicine) ;
  • Joe, Sook-Haeng (Department of Psychiatry, Korea University College of Medicine) ;
  • Jung, Hyun-Gang (Department of Psychiatry, Korea University College of Medicine)
  • 송민재 (고려대학교 의과대학 정신건강의학교실) ;
  • 조숙행 (고려대학교 의과대학 정신건강의학교실) ;
  • 정현강 (고려대학교 의과대학 정신건강의학교실)
  • Received : 2017.10.15
  • Accepted : 2017.12.22
  • Published : 2017.12.31

Abstract

Objectives : Middle aged women with depression often experience hot flush symptoms. It is still unclear about the association between depression and hot flush symptoms. Therefore, we investigated hormonal profile, functional somatic symptoms, coping styles and attitude for menopause between depressed women with hot flush and those without hot flush. Methods : This study included 33 depressed patients with hot flush symptoms and 33 depressed patients without hot flush symptoms. Hot flush was confirmed through prospective daily symptom ratings for a week. Subjects' coping styles were assessed by the stress coping checklist. Somatic symptoms were assessed by the Patient Health Questionnaire-15(PHQ-15). Sex hormonal levels were assayed by a radioimmunoassay. The Brief World Health Organization Quality of Life Assessment Instrument(WHOQOL-BREF) was used to evaluate quality of life. Results : In coping style, depressed women with hot flush symptoms used less 'problem-centered coping'($13.15{\pm}3.17$) and 'search for social support'($11.83{\pm}2.84$) than those without hot flush symptoms($15.17{\pm}3.1$, p=0.028 ; $14.25{\pm}3.22$, p=0.009 ; respectively). Depressed women with hot flush symptoms showed more negative attitude toward post-menopause, but its statistical significance was marginally insufficient(p=0.059). We did not find any group differences in sex hormonal levels and somatic complaints assessed by the PHQ-15. The score of social relationship domain of WHOQOL-BREF was significantly lower in subjects with hot flush symptoms($8.62{\pm}2.04$) than subjects without hot flush symptoms($9.71{\pm}1.65$ ; p=0.044). Conclusions : Among middle aged women with depression, the manifestation of hot flush symptoms was associated with coping styles and attitude for menopausal transition. Hot flush symptoms in depressed women negatively influence quality of life, so clinicians actively perform therapeutic approach in case of depressed patients with hot flush symptoms. In case of depressed patients who present hot flushes, cognitive behavior therapy or stress management might be an effective treatment option in company with antidepressants or hormonal treatment. Later, longitudinal study will be needed to evaluate risk factor, cause and effect associated with hot flush and depression.

연구목적 중년 우울증 여성은 안면 홍조 증상을 자주 경험한다. 우울증과 안면 홍조 간의 연관성은 아직 명확하지 않다. 따라서, 본 연구에서는 안면 홍조가 있는 우울증 여성과 안면 홍조가 없는 우울증 여성을 대상으로 호르몬 농도, 기능적 신체 증상, 폐경에 대한 태도 및 스트레스대처 방식을 비교하여 그 특성에 대해 알아보고자 하였다. 방 법 안면 홍조가 있는 우울증 여성 33명과 안면 홍조가 없는 우울증 여성 33명이 연구에 참여하였다. 안면 홍조 증상은 일주일에 걸쳐 전향적으로 일일 증상 척도를 통해 확인하였다. 연구 대상자의 스트레스 대처 방식은 스트레스 대처 방식 설문지를 통해 평가하였다. 신체 증상은 환자 건강 설문지(Patient Health Questionnaire-15, PHQ-15)로 평가하였다. 성 호르몬 농도는 방사성면역분석법으로 측정하였다. 간편 세계보건기구 삶의 질 평가도구(Brief World Health Organization Quality of Life Assessment Instrument, WHOQOL-BREF)를 이용하여 삶의 질을 평가하였다. 결 과 스트레스 대처 방식에 있어서, 안면 홍조가 있는 우울증 여성이 문제-중심의 대처 방식과($13.15{\pm}3.17$) 사회적 지지에 대한 탐색($11.83{\pm}2.84$) 항목이 안면 홍조 증상이 없는 우울증 여성에 비해 적었다(각각 $15.17{\pm}3.1$, p=0.028 ; $14.25{\pm}3.22$, p=0.009). 안면 홍조가 있는 우울증 여성이 폐경 후에 대하여 상대적으로 부정적 태도를 보였으나, 통계적 유의성은 근사치로 불충분하였다(p=0.059). 본 연구에서는 PHQ-15로 평가한 신체 증상과 성호르몬 농도에서 두 군 간의 차이를 발견하지 못 하였다. WHOQOL-BREF에 따른 사회적 대인 관계의 점수는 안면 홍조가 없는 군보다($9.71{\pm}1.65$ ; p=0.044) 안면 홍조가 있는 군에서($8.62{\pm}2.04$) 유의하게 낮았다. 결 론 우울증이 있는 중년 여성에서, 안면 홍조 증상은 스트레스에 대한 대처 방식의 영향을 받는 것으로 나타났다. 우울증 여성에서 안면 홍조 증상은 삶의 질에 부정적 영향을 주므로, 임상가는 안면 홍조가 있는 우울증 환자에서 적극적으로 안면 홍조에 대하여 치료적인 접근을 해야 할 것이다. 항우울제 혹은 소량의 호르몬 치료에 반응이 없는 우울증 환자에서, 인지 행동 치료 또는 스트레스 관리가 효과적일 수 있겠다. 추후 안면 홍조 및 우울증과 관련된 위험 요인에 대한 인과 관계를 명확하게 하기 위해서는 객관적인 방법을 통한 종적 연구가 필요할 것으로 생각된다.

Keywords

References

  1. Bromberger JT, Matthews KA, Schott LL, Brockwell S, Avis NE, Kravitz HM, Everson-Rose SA, Gold EB, Sowers MF, Randolph JF. Depressive symptoms during the menopausal transition: the Study of Women's Health Across the Nation (SWAN). Journal of Affective Disorders 2007;103: 267-272. https://doi.org/10.1016/j.jad.2007.01.034
  2. Cohen LS, Soares CN, Vitonis AF, Otto MW, Harlow BL. Risk for new onset of depression during the menopausal transition: the Harvard study of moods and cycles. Archives of General Psychiatry 2006;63:385-390. https://doi.org/10.1001/archpsyc.63.4.385
  3. Bromberger JT, Kravitz HM, Chang YF, Cyranowski JM, Brown C, Matthews KA. Major depression during and after the menopausal transition: Study of Women's Health Across the Nation(SWAN). Psychological Medicine 2011;41:1879-1888. https://doi.org/10.1017/S003329171100016X
  4. Joffe H, Hall JE, Soares CN, Hennen J, Reilly CJ, Carlson K, Cohen LS. Vasomotor symptoms are associated with depression in perimenopausal women seeking primary care. Menopause 2002;9:392-398. https://doi.org/10.1097/00042192-200211000-00003
  5. Freeman EW, Sammel MD, Lin H. Temporal associations of hot flashes and depression in the transition to menopause. Menopause 2009;16:728-734. https://doi.org/10.1097/gme.0b013e3181967e16
  6. Randolph JR, Sowers M, Bondarenko I, Gold EB, Greendale GA, Bromberger JT, Brockwell SE, Matthews KA. The relationship of longitudinal change in reproductive hormones and vasomotor symptoms during the menopausal transition. The Journal of Clinical Endocrinology & Metabolism 2005;90:6106-6112. https://doi.org/10.1210/jc.2005-1374
  7. Bromberger JT, Schott LL, Kravitz HM, Sowers M, Avis NE, Gold EB, Randolph JF, Matthews KA. Longitudinal change in reproductive hormones and depressive symptoms across the menopausal transition: results from the Study of Women's Health Across the Nation(swan). Archives of General Psychiatry 2010;67:598-607. https://doi.org/10.1001/archgenpsychiatry.2010.55
  8. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Diosrders(DSM-5(R)). American Psychiatric Pub;2013.
  9. Utian WH, Shoupe D, Bachmann G, Pinkerton JV, Pickar JH. Relief of vasomotor symptoms and vaginal atrophy with lower doses of conjugated equine estrogens and medroxyprogesterone acetate. Fertility and Sterility 2001;75:1065-1079. https://doi.org/10.1016/S0015-0282(01)01791-5
  10. Frank SH, Zyzanski SJ. Stress in the clinical setting: the Brief Encounter Psychosocial Instrument. Journal of Family Practice 1988;26:533-539.
  11. Bae JM, Jeong EK, Yoo TW, Huh BY. A quick measurement for stress in outpatient clinic setting. J Korean Acad Fam Med 1992;13:809-820.
  12. Yim JH, Bae JM, Choi SS, Kim SW, Hwang HS. Huh BY. The validity of modified Korean translated BEPSI as instrument of stress measurement in outpatient clinic. J Korean Acad Fam Med 1996;17:42-53.
  13. Kim EJ. The effect of self-representations and self consciousness on stress coping strategy. Hanyang University;1999.
  14. Folkman S, Lazarus R. Coping and adaption, in The Handbook of behavioral medicine. Guilford: New York;1984.
  15. Han C, Pae CU, Patkar AA, Masand PS, Kim KW, Joe SH, Jung IK. Psychometric properties of the Patient Health Questionnaire-15(PHQ-15) for measuring the somatic symptoms of psychiatric outpatients. Psychosomatics 2009;50:580-585.
  16. Spitzer RL, Kroenke K, Williams JB. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA 1999;282:1737-1744. https://doi.org/10.1001/jama.282.18.1737
  17. Spitzer RL, Williams JB, Kroenke K, Linzer M, Verloin deGruy F, Hahn SR, Brody DJ, Jeffery G. Utility of a new procedure for diagnosing mental disorders in primary care. The PRIME-MD 1000 study. JAMA 1994;272:1749-1756. https://doi.org/10.1001/jama.1994.03520220043029
  18. Kroenke K, Spitzer RL, Williams JB. The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms. Psychosom Med 2002;64:258-266. https://doi.org/10.1097/00006842-200203000-00008
  19. WHOQOL Group. Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychological Medicine 1998;28):551-558. https://doi.org/10.1017/S0033291798006667
  20. Min SK, Lee CI, Kim KI, Suh SY, Kim DK. Development of Korean version of WHO quality of life scale abbreviated version(WHOQOLBREF). J Korean Neuropsychiatry Assoc 2000; 39:571-579.
  21. Cheng MH, Wang SJ, Wang PH, Fuh JL. Attitudes toward menopause among middle-aged women: a community survey in an island of Taiwan. Maturitas 2005;52:348-355. https://doi.org/10.1016/j.maturitas.2005.06.001
  22. Lee YH, Song JY. A study of the reliability and the validity of the BDI, SDS, and MMPI-D scales. Journal of Korean Psychiatric Association 1991;10:98-113.
  23. Jo SA, Park MH, Jo I, Ryu SH, Han C. Usefulness of Beck Depression Inventory(BDI) in the Korean elderly population. International Journal of Geriatric Psychiatry 2007;22:218-223. https://doi.org/10.1002/gps.1664
  24. Beck AT. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561-567. https://doi.org/10.1001/archpsyc.1961.01710120031004
  25. Spielberger CD, Gorsuch RL, Lushene PR, Vagg PR, Jacobs AG. Manual for the State-Trait Anxiety Inventory. Consulting Psychologist Press, Inc;1983.
  26. Hunter MS, Mann E. A cognitive model of menopausal hot flushes and night sweats. Journal of Psychosomatic Research 2010;69:491-501. https://doi.org/10.1016/j.jpsychores.2010.04.005
  27. Ayers B, Forshaw M, Hunter MS. The impact of attitudes towards the menopause on women's symptom experience: A systematic review. Maturitas 2010;65:28-36. https://doi.org/10.1016/j.maturitas.2009.10.016
  28. Blumel JEM, Castelo-Branco CM, Maria JC, Cordova AT, Binfa LE, Bonila HG, Munoz IG, Vergara VG, Sarra SC. Relationship between psychological complaints and vasomotor symptoms during climacteric. Mauritas;2004.
  29. Freedman RR. Pathophysiology and treatment of menopausal hot flashes. Seminars in Reproductive Medicine 2005;23:117-125.
  30. Farquhar C, Marjoribanks J, Lethaby A, Suckling JA, Lamberts Q. Long term hormone therapy for perimenopausal and postmenopausal women. The Cochrane Library;2009.
  31. Norton S, Chilcot J, Hunter MS. Cognitive-behavior therapy for menopausal symptoms(hot flushes and night sweats): moderators and mediators of treatment effects. Menopause;2013.
  32. Generali J, Cada DJ. Venlafaxine: Hot Flashes. Hospital Pharmacy 2001;36:870-877. https://doi.org/10.1177/001857870103600811